FDA clears Gilead’s hepatitis D drug, four years after prior rejectionnews2026-05-22T18:35:28+00:00May 22nd, 2026|Endpoints News|
BMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campusnews2026-05-21T13:02:14+00:00May 21st, 2026|Endpoints News|
GHO Capital, CBC Group to merge, forming what could be the largest healthcare specialist investornews2026-05-20T10:22:22+00:00May 20th, 2026|Endpoints News|
Drugmakers have to go through rigorous tests to get a lower tariff ratenews2026-05-14T16:00:16+00:00May 14th, 2026|Endpoints News|
MacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attacknews2026-05-14T14:10:18+00:00May 14th, 2026|Endpoints News|
Merck KGaA’s clients are stockpiling due to Iran war, supporting guidance boostnews2026-05-13T11:01:36+00:00May 13th, 2026|Endpoints News|
EU reaches provisional deal on Critical Medicines Actnews2026-05-12T17:47:10+00:00May 12th, 2026|Endpoints News|
Iran war disruptions begin to emerge upstream of the pharma supply chainnews2026-05-12T17:04:25+00:00May 12th, 2026|Endpoints News|
CSL sinks to nine-year low on revenue warning, $5B write-downnews2026-05-11T10:30:09+00:00May 11th, 2026|Endpoints News|
Daiichi Sankyo posts ‘extraordinary loss’ of nearly $1Bnews2026-05-08T17:16:32+00:00May 8th, 2026|Endpoints News|
